This article has been cited by other articles in PMC.
Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (238K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
These references are in PubMed. This may not be the complete list of references from this article.
Simpson HC, Mann JI, Meade TW, Chakrabarti R, Stirling Y, Woolf L. Hypertriglyceridaemia and hypercoagulability. Lancet. 1983 Apr 9;1(8328):786–790.[PubMed]
Almér LO, Kjellström T. The fibrinolytic system and coagulation during bezafibrate treatment of hypertriglyceridemia. Atherosclerosis. 1986 Jul;61(1):81–85.[PubMed]
Mikhailidis DP, Barradas MA, Maris A, Jeremy JY, Dandona P. Fibrinogen mediated activation of platelet aggregation and thromboxane A2 release: pathological implications in vascular disease. J Clin Pathol. 1985 Oct;38(10):1166–1171.[PMC free article][PubMed]
Carlson TH, Wentland SH, Leonard BD, Ruder MA, Reeve EB. Effects of prostaglandin E2, analogs, fatty acids, and indomethacin on fibrinogen level. Am J Physiol. 1978 Aug;235(2):H223–H230.[PubMed]
Mikhailidis DP, Kirtland SJ, Barradas MA, Mahadeviah S, Dandona P. The effect of dihomogammalinolenic acid on platelet aggregation and prostaglandin release, erythrocyte membrane fatty acids and serum lipids: evidence for defects in PGE1 synthesis and delta 5-desaturase activity in insulin-dependent diabetics. Diabetes Res. 1986 Jan;3(1):7–12.[PubMed]
Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press